Medicare Expands Coverage for GLP-1 Drugs
Medicare will begin covering certain GLP-1 medications for weight loss. This change aims to improve access for older adults. (sources: cbsnews, nytimes)
Medicare will start covering some GLP-1 medications, including Wegovy and Zepbound, as part of a pilot program. This initiative is particularly relevant for patients over 65, who may face unique risks.
- Medicare coverage for GLP-1 drugs begins on Wednesday.
- The pilot program aims to increase access to weight loss medications.
- Patients over 65 may experience specific health risks associated with these drugs.
Why it matters
This expansion of coverage may provide older adults with more treatment options for weight management.
↓ Congress can act on this
3 bills on this issue are moving right now — and the most active one is H.R.4231: Treat and Reduce Obesity Act of 2025.
H.R.4231 · 119th Congress
Treat and Reduce Obesity Act of 2025
Where do you stand on this bill?
Takes about 60 seconds
About this bill
What H.R.4231 actually does
This story is about about Medicare covering GLP-1 drugs. This bill would let Medicare Part D cover drugs used to treat obesity or manag
2 other bills moving on this issue
Take action on any of them individually.
This story is about about Medicare covering GLP-1 drugs. This bill would open Medicare Part D to obesity drugs and broaden Medicare obes
Take action on S1973 →This story is about about Medicare covering GLP-1 drugs. This bill would this bill is about making medical nutrition therapy services easier to access for people on Medicare.
Take action on HR6199 →